Recently, several novel sEV screening methods including microfluidic chips [151], surface enhanced Raman scattering nanotags [152], and DNA aptamer-mediated microfluidics [153] have demonstrated simple and time-saving ways to profile sEV EpCAM and HER2 proteins for diagnosis of HER2+ BC. Here, ERBB2 is linked to breast cancer.